- Report
- July 2023
- 140 Pages
Global
From €4345EUR$4,949USD£3,800GBP
- Report
- August 2024
- 135 Pages
Global
From €2601EUR$2,963USD£2,275GBP
€3468EUR$3,950USD£3,033GBP
- Report
- January 2023
- 132 Pages
Global
From €2930EUR$3,338USD£2,563GBP
€3907EUR$4,450USD£3,417GBP
- Report
- September 2024
- 150 Pages
Global
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- November 2024
- 150 Pages
Global
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- September 2024
- 150 Pages
Global
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- September 2022
- 134 Pages
From €3029EUR$3,450USD£2,649GBP
- Report
- September 2022
- 150 Pages
Africa, Middle East
From €3029EUR$3,450USD£2,649GBP
- Report
- September 2022
- 181 Pages
Asia Pacific
From €3029EUR$3,450USD£2,649GBP
- Report
- September 2022
- 157 Pages
Europe
From €3029EUR$3,450USD£2,649GBP
- Report
- September 2022
- 127 Pages
North America
From €3029EUR$3,450USD£2,649GBP
- Report
- June 2023
- 76 Pages
Global
From €3068EUR$3,495USD£2,684GBP
- Report
- August 2022
- 109 Pages
Global
From €3468EUR$3,950USD£3,033GBP
- Report
- December 2024
- 150 Pages
Global
From €3468EUR$3,950USD£3,033GBP
- Report
- August 2023
- 85 Pages
United States
From €4258EUR$4,850USD£3,724GBP
- Report
- April 2022
Global
€7024EUR$8,000USD£6,143GBP
- Clinical Trials
- September 2018
- 700 Pages
Global
From €2634EUR$3,000USD£2,303GBP
- Report
- January 2024
- 83 Pages
Global
From €3500EUR$4,271USD£3,168GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,271USD£3,168GBP
- Report
- June 2024
- 92 Pages
Global
From €3500EUR$4,271USD£3,168GBP

The Cancer Vaccines market is a rapidly growing sector of the healthcare industry. It is focused on the development of vaccines to prevent and treat cancer. These vaccines are designed to stimulate the body's immune system to recognize and attack cancer cells. The goal is to reduce the risk of cancer recurrence and improve the quality of life for cancer patients.
The Cancer Vaccines market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotechnology firms. These companies are involved in the research, development, and production of cancer vaccines. They are also involved in clinical trials to test the safety and efficacy of these vaccines.
Some of the major players in the Cancer Vaccines market include Merck, GlaxoSmithKline, Pfizer, Sanofi, and Johnson & Johnson. These companies are actively involved in the development of cancer vaccines and are working to bring new treatments to the market. Show Less Read more